In 2016, the Center for Disease Control (CDC) analyzed data from the National Health Interview Survey to investigate the prevalence of chronic pain in the United States. They found that an estimated 20.4% of U.S. adults (50 million people) had chronic pain. Additionally, “high-impact” (more severe, limiting) chronic pain was found in an estimated 8.0% of U.S. adults (19.6 million people).
When people have certain types of chronic pain that are not easily manageable, intravenous (IV) ketamine treatment is an alternative, cutting-edge option to consider. For our chronic pain patients at Reset Ketamine, we implement treatments ranging from 80 minutes to 4 hours depending upon the patient’s clinical diagnosis. Additionally, we often increase the dose after each infusion in order to maximize the effect of ketamine as part of the patient’s tailored treatment plan.